IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v365y2025ics0277953624010086.html
   My bibliography  Save this article

‘Small benefits and a certain risk’: Media representations of novel treatments for Alzheimer's disease

Author

Listed:
  • Abeysinghe, Sudeepa
  • Tao, Yu
  • Kyei-Baffour, Priscilla
  • Adrion, Emily

Abstract

The media is a key site for developing and communicating public understanding of Alzheimer's disease. Alzheimer's disease is a leading cause of dementia, and a condition that is prominent in public perceptions of ageing and cognitive decline. Novel disease-modifying treatments (DMTs) are the first innovation in Alzheimer's disease treatment for two decades, and have the potential to change how society thinks about Alzheimer's disease. This study investigates representation of risks and uncertainties of DMTs in articles published within the five highest circulation US newspapers between November 2020 and May 2024. This was a period of focused media attention on DMTs in the US, including reporting on Food and Drug Administration (FDA) review and approval processes and debates over public funding of these treatments through the Medicare program. The analysis finds that the media associated risks with the relative efficacy of the medications in comparison to the costs of these treatments. We further find that media representations highlight institutional challenges for the FDA in managing these uncertainties, within a situation characterized by expert contestation of the evidentiary basis for DMTs and patient hope for the promise that DMTs hold.

Suggested Citation

  • Abeysinghe, Sudeepa & Tao, Yu & Kyei-Baffour, Priscilla & Adrion, Emily, 2025. "‘Small benefits and a certain risk’: Media representations of novel treatments for Alzheimer's disease," Social Science & Medicine, Elsevier, vol. 365(C).
    • Handle: RePEc:eee:socmed:v:365:y:2025:i:c:s0277953624010086
    DOI: 10.1016/j.socscimed.2024.117554
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0277953624010086
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.socscimed.2024.117554?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:365:y:2025:i:c:s0277953624010086. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.